Top Markets
Coin of the day
MaaT Pharma S.A. MaaT Pharma S.A.

MaaT Pharma S.A.

MAAT
Clasificación en acciones #23616
MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on... MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.
Precio por acción
$3.78
Última sincronización: 2026-08-21
Capitalización bursátil
$71.20M
Cambio (1 día)
2.24%
Cambio (1 año)
-43.37%
País
FR
Comercio MaaT Pharma S.A. (MAAT)

Categoría

Historial del precio de la acción de MaaT Pharma S.A. (MAAT)
Precio más alto de cierre: $3.53 el 2026-08-01

Precio más bajo de cierre: $15.22 el 2021-11-01
Historial del precio de la acción de MaaT Pharma S.A. desde 2021 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 10.63%
2025 -39.72%
2024 11.45%
2023 -18.97%
2022 -38.00%
2021 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH